Grandfield & Dodd’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.68M | Sell |
18,564
-3,503
| -16% | -$321K | 0.09% | 93 |
|
|
2025
Q4 | $1.98M | Sell |
22,067
-12,165
| -36% | -$1.15M | 0.11% | 89 |
|
|
2025
Q3 | $3.37M | Sell |
34,232
-4,138
| -11% | -$410K | 0.19% | 70 |
|
|
2025
Q2 | $3.5M | Sell |
38,370
-7,500
| -16% | -$725K | 0.2% | 68 |
|
|
2025
Q1 | $5.19M | Sell |
45,870
-2,075
| -4% | -$222K | 0.32% | 58 |
|
|
2024
Q4 | $5.06M | Sell |
47,945
-11,072
| -19% | -$1.19M | 0.31% | 59 |
|
|
2024
Q3 | $6.37M | Sell |
59,017
-13,237
| -18% | -$1.44M | 0.38% | 55 |
|
|
2024
Q2 | $7.84M | Sell |
72,254
-23,628
| -25% | -$2.79M | 0.5% | 52 |
|
|
2024
Q1 | $12.7M | Sell |
95,882
-23,684
| -20% | -$2.96M | 0.8% | 44 |
|
|
2023
Q4 | $14.6M | Sell |
119,566
-7,250
| -6% | -$809K | 1.01% | 40 |
|
|
2023
Q3 | $14.2M | Sell |
126,816
-528
| -0.4% | -$67.1K | 1.05% | 40 |
|
|
2023
Q2 | $18.5M | Sell |
127,344
-176
| -0.1% | -$23.9K | 1.3% | 31 |
|
|
2023
Q1 | $16.5M | Sell |
127,520
-245
| -0.2% | -$30.8K | 1.15% | 38 |
|
|
2022
Q4 | $16.3M | Sell |
127,765
-162
| -0.1% | -$18.8K | 1.19% | 39 |
|
|
2022
Q3 | $13.4M | Sell |
127,927
-1,397
| -1% | -$153K | 1.09% | 40 |
|
|
2022
Q2 | $13.6M | Buy |
129,324
+1,890
| +1% | +$224K | 1.07% | 42 |
|
|
2022
Q1 | $16.3M | Sell |
127,434
-4,014
| -3% | -$484K | 1.11% | 39 |
|
|
2021
Q4 | $16.2M | Buy |
131,448
+57
| +0% | +$7.46K | 1.04% | 40 |
|
|
2021
Q3 | $18.7M | Sell |
131,391
-230
| -0.2% | -$33.8K | 1.3% | 30 |
|
|
2021
Q2 | $20.6M | Buy |
131,621
+174
| +0.1% | +$28.2K | 1.42% | 31 |
|
|
2021
Q1 | $20.4M | Sell |
131,447
-1,077
| -0.8% | -$167K | 1.53% | 28 |
|
|
2020
Q4 | $19.8M | Sell |
132,524
-381
| -0.3% | -$53.8K | 1.56% | 26 |
|
|
2020
Q3 | $17.6M | Buy |
132,905
+1,519
| +1% | +$198K | 1.58% | 24 |
|
|
2020
Q2 | $15.2M | Sell |
131,386
-960
| -0.7% | -$111K | 1.47% | 23 |
|
|
2020
Q1 | $13M | Buy |
132,346
+402
| +0.3% | +$52.7K | 1.53% | 25 |
|
|
2019
Q4 | $19.2M | Buy |
131,944
+695
| +0.5% | +$95.9K | 1.75% | 20 |
|
|
2019
Q3 | $17.5M | Buy |
131,249
+188
| +0.1% | +$24.3K | 1.72% | 18 |
|
|
2019
Q2 | $15M | Buy |
131,061
+692
| +0.5% | +$81K | 1.48% | 23 |
|
|
2019
Q1 | $16.2M | Buy |
130,369
+309
| +0.2% | +$35.1K | 1.68% | 19 |
|
|
2018
Q4 | $13.1M | Sell |
130,060
-958
| -0.7% | -$108K | 1.55% | 22 |
|
|
2018
Q3 | $16.7M | Buy |
131,018
+3,126
| +2% | +$372K | 1.72% | 21 |
|
|
2018
Q2 | $13.8M | Buy |
127,892
+3,124
| +3% | +$340K | 1.52% | 24 |
|
|
2018
Q1 | $13.2M | Buy |
124,768
+4,952
| +4% | +$575K | 1.47% | 28 |
|
|
2017
Q4 | $14M | Buy |
119,816
+9,662
| +9% | +$1.09M | 1.5% | 27 |
|
|
2017
Q3 | $12.5M | Buy |
110,154
+4,748
| +5% | +$548K | 1.41% | 30 |
|
|
2017
Q2 | $13.1M | Buy |
105,406
+512
| +0.5% | +$60.7K | 1.55% | 28 |
|
|
2017
Q1 | $12.4M | Buy |
104,894
+2,342
| +2% | +$265K | 1.54% | 26 |
|
|
2016
Q4 | $10.3M | Buy |
102,552
+10,190
| +11% | +$1.09M | 1.33% | 30 |
|
|
2016
Q3 | $11.7M | Buy |
92,362
+1,448
| +2% | +$179K | 1.53% | 28 |
|
|
2016
Q2 | $10.6M | Buy |
90,914
+1,597
| +2% | +$181K | 1.49% | 28 |
|
|
2016
Q1 | $9.25M | Buy |
89,317
+1,205
| +1% | +$117K | 1.34% | 32 |
|
|
2015
Q4 | $8.78M | Buy |
88,112
+6,180
| +8% | +$605K | 1.33% | 32 |
|
|
2015
Q3 | $7.47M | Buy |
81,932
+269
| +0.3% | +$27K | 1.25% | 33 |
|
|
2015
Q2 | $8.66M | Buy |
81,663
+116
| +0.1% | +$12.8K | 1.32% | 36 |
|
|
2015
Q1 | $9.3M | Buy |
81,547
+1,900
| +2% | +$217K | 1.42% | 35 |
|
|
2014
Q4 | $8.77M | Buy |
79,647
+31
| +0% | +$3.27K | 1.36% | 34 |
|
|
2014
Q3 | $7.77M | Buy |
79,616
+36
| +0% | +$3.54K | 1.22% | 37 |
|
|
2014
Q2 | $8.02M | Sell |
79,580
-1,267
| -2% | -$124K | 1.21% | 35 |
|
|
2014
Q1 | $7.42M | Buy |
80,847
+4,182
| +5% | +$385K | 1.17% | 37 |
|
|
2013
Q4 | $6.94M | Buy |
76,665
+5,650
| +8% | +$489K | 1.13% | 39 |
|
|
2013
Q3 | $5.66M | Buy |
71,015
+29,113
| +69% | +$2.29M | 1.01% | 41 |
|
|
2013
Q2 | $3.05M | Buy |
+41,902
| New | +$3.13M | 0.58% | 53 |
|
Other funds holding ZBH
VCM
VPM
Grandfield & Dodd's ZBH Position: Q1 2026 in Review
Grandfield & Dodd reduced its Zimmer Biomet (ZBH) stake by 16% in Q1 2026, selling an estimated $321K and leaving 18,564 shares worth $1.68M. The position accounts for 0.09% of the portfolio, ranked #93.
Grandfield & Dodd first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.6M in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Grandfield & Dodd held 18,564 shares of Zimmer Biomet worth $1.68M as of Q1 2026.
- Grandfield & Dodd sold 3,503 Zimmer Biomet shares in Q1 2026, an estimated $321K.
- Zimmer Biomet made up 0.09% of Grandfield & Dodd's portfolio in Q1 2026, its #93 holding.
- Grandfield & Dodd first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Grandfield & Dodd's Zimmer Biomet position peaked at $20.6M in Q2 2021.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Grandfield & Dodd's 13F filing for Q1 2026, filed 7 May 2026.